RP Bio Inc. (KOSDAQ:314140)

RP Bio Revenue

RP Bio had revenue of 35.13B KRW in the quarter ending March 31, 2026, with 3.34% growth. This brings the company's revenue in the last twelve months to 137.35B, up 9.47% year-over-year. In the year 2025, RP Bio had annual revenue of 136.22B with 9.88% growth.

• Revenue (ttm): 137.35B
• Revenue Growth: +9.47%
• P/S Ratio: 0.34
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 46.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	136.22B	12.25B	9.88%
Dec 31, 2024	123.97B	-27.08B	-17.93%
Dec 31, 2023	151.05B	12.94B	9.37%
Dec 31, 2022	138.11B	23.15B	20.13%
Dec 31, 2021	114.96B	17.04B	17.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error